A Phase I Trial of Pevonedistat Given in Combination with Fludarabine, Cytarabine, and Azacitidine in Children, Adolscents, and Young Adults with Relapsed or Refractory Acute Myeloid Leukemia
|Effective start/end date||10/22/19 → 10/21/22|
- Children's Hospital of Philadelphia
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.